British American Tobacco p.l.c.
No SEC Form 4 filings for $BTI in the last 30 days.
See all $BTI insider activity →Major tobacco companies are expanding their higher-strength nicotine pouch offerings in the $5.2B U.S. market. Philip Morris, BAT, and Altria are launching or expanding products with higher nicotine levels. U.S. pouch sales reached 21B last year, with smokeless nicotine products up 8% in 2026, while cigarette sales declined 2.4%.
British American Tobacco (BTI) filed a Form 6-K on August 26, 2026, disclosing transactions by senior managers and associates. The report includes a press release as an exhibit, detailing these transactions. BTI is a foreign private issuer, subject to different U.S. reporting rules. The filing provides transparency for investors regarding managerial activities.
The nicotine pouch market, led by Philip Morris International (PMI) and British American Tobacco (BAT), is projected to reach ¥1.1 trillion by 2030. BAT forecasts revenue growth from £4 billion in 2025 to £11 billion by 2030, with 47 million users. PMI's 'Zyn' and BAT's 'Velo' are key products. High profit margins and global expansion drive investor interest, though regulatory changes and cultural barriers pose challenges.
Over the past 7 days, alphai's AI scored 3 news stories mentioning BTI (British American Tobacco p.l.c.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent BTI coverage spans sector analysis, financial news and regulation.
Launch may boost sales volume in the growing high‑strength segment.
The filing provides transparency but contains no new financial data or material events.
Strong growth forecasts may lift BTI valuation.
Potential market reaction to insider shareholding update.
Potential multibillion‑pound liability could pressure BTI share price and increase legal cost exposure.
alphai scores every news story that mentions BTI with an AI model for sentiment and relevance, and aggregates insider trades from British American Tobacco p.l.c.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Major tobacco companies are expanding their higher-strength nicotine pouch offerings in the $5.2B U.S. market. Philip Morris, BAT, and Altria are launching or expanding products with higher nicotine levels. U.S. pouch sales reached 21B last year, with smokeless nicotine products up 8% in 2026, while cigarette sales declined 2.4%.
2 min readBritish American Tobacco (BTI) filed a Form 6-K on August 26, 2026, disclosing transactions by senior managers and associates. The report includes a press release as an exhibit, detailing these transactions. BTI is a foreign private issuer, subject to different U.S. reporting rules. The filing provides transparency for investors regarding managerial activities.
1 min readThe nicotine pouch market, led by Philip Morris International (PMI) and British American Tobacco (BAT), is projected to reach ¥1.1 trillion by 2030. BAT forecasts revenue growth from £4 billion in 2025 to £11 billion by 2030, with 47 million users. PMI's 'Zyn' and BAT's 'Velo' are key products. High profit margins and global expansion drive investor interest, though regulatory changes and cultural barriers pose challenges.
4 min readBritish American Tobacco (BATS) disclosed transactions by persons discharging managerial responsibilities on 20 August 2026. The notification was made by Nancy Jiang, an officer of the issuer.
1 min readBritish American Tobacco (BAT) agreed to pay $1.1 billion in penalties and settlements to the US government for violating North Korean sanctions. Now, BAT faces shareholder litigation in the UK and terrorism-related claims in the US, highlighting risks of derivative actions after resolving government enforcement actions.
3 min readBritish American Tobacco (BTI) filed a Form 6-K report, disclosing three press releases about transactions by executives and their associates. The company, a foreign private issuer, provided notifications but no specific details on the transactions. The report was signed by Nancy Jiang, Senior Assistant Company Secretary.
1 min readReuters reports nicotine pouches are a key growth bet for Big Tobacco as cigarette sales decline. It cites Philip Morris International’s Zyn and BAT’s Velo, with BAT reporting 27.5% pouch volume growth to about 700 million in H1 2026 and predicting £11bn pouch revenue by 2030. Regulators including the FDA and WHO are tightening rules over youth uptake and marketing.
6 min readDenver sued nine tobacco manufacturers and one distributor in state court, seeking compensation for cleanup and “continuing harms” from cigarette butt litter, citing non-biodegradable filters. The complaint names Philip Morris USA, Altria, R.J. Reynolds, Reynolds American, British American Tobacco and others, alleging littering is a foreseeable consequence of product design and marketing.
6 min readFTSE 100 closed down 0.4% at 10,862.50 and FTSE 250 down 0.4% at 24,744.54 as oil rose on Iran Strait of Hormuz reopening concerns. Brent October traded at $86.35/bbl. BP and Shell gained, while BAT and Imperial Brands fell. Persimmon and Barratt Redrow dropped on higher bond yields; Plus500 reported 12% revenue growth.
6 min readBritish American Tobacco (BTI) reported Q2 2026 results, citing 2.9% group revenue growth at constant currency and a 7.9% rise in adjusted diluted EPS. Smokeless revenue was 19.8% of group revenue, with 35 million consumers. Heated product revenue fell 12%. Full-year EPS guidance was upgraded to the mid-point of a 5% to 8% range, alongside a GBP 1.3 billion 2026 buyback.
10 min read
